Trial Profile
Safety and Efficacy Study of Mitoxantrone Hydrochloride Liposome Injection Plus Cyclophosphamide,Vincristine and Prednison (CNOP)in Diffuse Large B Cell Lymphoma
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 26 May 2017
Price :
$35
*
At a glance
- Drugs Mitoxantrone liposomal (Primary) ; Cyclophosphamide; Prednisone; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Sponsors CSPC ZhongQi Pharmaceutical Technology
- 22 May 2017 Status changed from recruiting to withdrawn prior to enrolment.
- 06 Nov 2015 New trial record